Instrument overview

BTECiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)

ETFLSEアイルランドEU retail: available

+3.2% today · +36.2% over a year

7/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced»

Trend: among the best of its peers. No dividend.

Balanced 7/107/10Balanced
Weights for long-horizon accumulation: more quality and trend, no dividend requirement. These are three ways to weigh the same factors, not three properties of the instrument; Income compares within the sector, so a low yield can still score high. More in the glossary →8/10
Default weights: value, quality, trend, stability and dividend safety together. These are three ways to weigh the same factors, not three properties of the instrument; Income compares within the sector, so a low yield can still score high. More in the glossary →7/10
Weights for income: dividend safety counts most; shown for dividend payers only. These are three ways to weigh the same factors, not three properties of the instrument; Income compares within the sector, so a low yield can still score high. More in the glossary →6/10

The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.

Compared with: instruments of the same type (n = 155)

Current rating first published: · last recomputed · rating log

Factor scores

Price trend over the last 12 and 6 months (excluding the last month) and distance from the 52-week high. More in the glossary →better than 87% of peers
Lower price swings, lower market sensitivity (beta) and shallower drawdowns score higher. More in the glossary →better than 33% of peers
Ongoing charges versus similar funds and the legal structure (UCITS / key information document).better than 54% of peers

Percentiles within the peer group (100 = the best of its peers); dividend safety in points.

Main drivers

  • 12-month trend (ex last month)supports the score · better than 90% of peers
  • Max drawdown (3 y)weighs on the score · better than 26% of peers
  • 6-month trend (ex last month)supports the score · better than 86% of peers

Red flags and notes

No red flagsNone of our published warning rules is triggered right now.

Price chart

Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.

Key metrics

Fund

Ongoing charges (TER)
0.35%
Income
Accumulating

Dividends

Dividend yield
0.00%
Years of dividend growth
0

Returns and risk

1 day
+3.2%
1 month
+2.4%
1 year
+36.2%
Volatility, 1 yr
21.5%
Max drawdown, 1 yr
−9.6%
Beta
0.82

Returns are price changes from end-of-day prices, without dividends.

News and filings

No recent news or filings in our sources.

Score changes in the last 12 months

Every published rating and change, logged when it was published (EU Market Abuse Regulation).

Show the log: 1 entries
DateEventBalancedGrowth · IncomeWarningsPrice at publication
First rating 7/10 8 · 6 — Available with Invest Pro

Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.